VRI BioMedical Limited has announced that it has successfully completed its fully underwritten rights issue, raising $2.8 million.
Private shareholders and institutions took up 51.68 per cent of their entitlements.
The rights issue, together with a recent placement to institutional shareholders has raised more than $4.3 million for the company.
VRI finished the 2002-03 financial year with a net loss of $5.1 million.